Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | BTK | Q06187 | 1/20 | 0.30 |
| ▸ | RET | P07949 | 1/20 | 0.30 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31190804 | 0.85 | CYP4F2 (0.33) | CYP4F2CYP4A11RET | |
| SCHEMBL29925580 | 0.78 | RXRA (0.35) | CYP4F2CYP4A11RETDGAT2 | |
| SCHEMBL26741104 | 0.78 | RXRA (0.35) | CYP4F2CYP4A11RETDGAT2 | |
| SCHEMBL29950914 | 0.73 | GAA (0.40) | CYP4F2CYP4A11RETDGAT2 | |
| SCHEMBL30713609 | 0.73 | CYP4F2 (0.31) | CYP4F2CYP4A11RET | |
| SCHEMBL30540754 | 0.72 | EGFR (0.37) | CYP4F2CYP4A11EGFRBTKRET | |
| SCHEMBL24606751 | 0.72 | ATR (0.30) | CYP4F2CYP4A11RET | |
| SCHEMBL25029231 | 0.71 | CYP4F2 (0.38) | CYP4F2CYP4A11RET | |
| SCHEMBL30540775 | 0.69 | RET (0.32) | CYP4F2CYP4A11RET | |
| SCHEMBL29361551 | 0.69 | CYP4F2 (0.40) | CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4146658-B1 | NEW MACROCYCLIC LRRK2 KINASE INHIBITORS | ONCODESIGN PREC MEDICINE OPM (FR) | 2025-10-29 | — | — | EP | disclosed |